Authors
Latest:
Copayment Level and Drug Switching: Findings for Type 2 DiabetesAmong insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.
Latest:
Chemotherapy and ObesityWhen giving antineoplastics to obese and morbidly obese patients, clinicians must be careful not to under- or overdose.
Latest:
What Are the Implications of the MERINO Trial?Is piperacillin/tazobactam an effective carbapenem alternative to treat bloodstream infections caused by ESBL-producing enterobacteriaceae.
Latest:
Review of Outcomes Associated With Formulary Restrictions: Focus on Step TherapyAs healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
Latest:
Patient-Centered Care: The Case for Site Expansion to Include Health System Specialty PharmacyHealth systems and manufacturers need to work together to obtain inclusion for health system specialty pharmacies so that patients can fill their prescriptions within a coordinated care ecosystem.
Latest:
Pharmacy Technicians Contribute to Positive Outcomes for Patients Using Opioids by Avoiding StigmaPerhaps no other health care worker has been exposed to the opioid epidemic more frequently than pharmacy technicians and pharmacists.
Latest:
Hepatitis C Management: How Payers, Providers, and Pharmacies Can Work Together to Stem CostsNew models of collaboration can guide providers in optimizing care for patients with HCV.
Latest:
Copayment Level and Drug Switching: Findings for Type 2 DiabetesAmong insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.
Latest:
Justice Department Places Increased Scrutiny On Pharmacies, PharmacistsFederal prosecutors are increasingly turning their attention to pharmacies and pharmacists. In this article, we detail some of the recent enforcement efforts, as well as outline some proactive strategies for compliance.
Latest:
Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder InterventionsThis cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.
Latest:
Prostate Cancer: Facts, Causes, and TreatmentsProstate cancer is the leading cancer in men, with about 1 in 8 developing it in his lifetime.
Latest:
Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.
Latest:
Non-oral PrEP Options Are Being Investigated to Improve Patient AdherenceAdditional non-oral options could provide more manageable forms of PrEP treatment for patients, potentially increasing global uptake of PrEP in the future.
Latest:
Ostomy Wound Management Options ExaminedPatients with wounds often take pharmacological agents for wound treatment or illness management.
Latest:
Satellite Instruction Presents Challenges for Pharmacy StudentsWe are training to become members of a health care team, which requires us to be connected and work with others to provide the best care possible for our patients.
Latest:
Impact of Patient Cost Sharing on Multiple Sclerosis TreatmentThis study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.
Latest:
Pertussis Vaccine Appears to Lose Strength Over TimeA new study finds that the effectiveness of the pertussis vaccine wanes in the 5 years after children receive their last dose, which may help explain recent outbreaks.
Latest:
Pharmacist Management of Alpelisib-Associated HyperglycemiaThe selection of an agent for hyperglycemia management requires knowledge of both the efficacy and the potential adverse effects of each possible agent, so choosing the best therapy for any given patient can be complicated.
Latest:
Electronic Prescribing of Controlled Substances: A Tool to Help Promote Better Patient CareThis study presents the first information available regarding enablement and use by state and area characteristics of electronic prescribing of controlled substances by prescribers and pharmacy systems in from an e-prescribing network.
Latest:
New Jersey Pharmacists' Perceptions of the New Jersey Prescription Monitoring ProgramWith prescription opioid overdoses leading to more deaths in the United States each year than cocaine and heroin combined, prescription drug abuse, misuse, and diversion have become growing concerns.
Latest:
Overcoming Challenges of Insulin Therapy in Type 2 Diabetes: Exploring Emerging OptionsThis Continuing Education activity is supported by an educational grant from Sanofi-Aventis U.S.
Latest:
Work Productivity Associated With Treated Versus Never-Treated Overactive Bladder SymptomsOveractive bladder symptoms can impair work productivity, especially among untreated adults, with work productivity impairment costs nearly twice as high for never-treated versus treated subjects.
Latest:
Walmart Essay Winner: Helping Patients Live Better, Healthier LivesI consider it a great privilege to be able to serve my patients and empower them to improve their health.
Latest:
Combatting Alert Fatigue: Holistically Reducing Noise at the Point of CareAdopting and implementing clinical decision support (CDS) technology is a critical element of efforts to advance national quality initiatives and evidence-based practices at the point of care.
Latest:
Will Resistance Associated Variants Affect the HCV Treatment Paradigm?Specialty pharmacists play an important role in making evidence-based recommendations for the treatment of hepatitis C virus.
Latest:
Second Look at Utilization of a Closed-System Transfer Device (PhaSeal)The Phaseal closed-system transfer device can extend the beyond-use date of pharmaceuticals, thereby reducing waste.
